Mitral and aortic valve replacement in children: Last decade results with latest generation prothesis
PDF (Español (España))

Keywords

Pediatrics
Valve Replacement
Anticoagulant Therapy
Surgery
Cardiology
Heart Surgery
Heart Valve Diseases

How to Cite

1.
Becker R. P, Frangini S. P, Arretz V. C, Heusser R. F, Urcelay M. G, Zalaquett S. R, Irarrázaval L. MJ, Morán V. S, Arnaiz G. P, Garay G. F, Clavería R. C, Castillo N. ME. Mitral and aortic valve replacement in children: Last decade results with latest generation prothesis. Andes pediatr [Internet]. 2005 Jul. 8 [cited 2025 Dec. 29];76(4):375-83. Available from: https://andespediatrica.cl/index.php/rchped/article/view/2137

Abstract

Introduction: Mitral (MVR) and aortic (AVR) valve replacement are uncommon interventions in pediatric patients and the published series report high morbidity and mortality. 

Objective: Evaluate mid-term results in children with MVR and AVR during the last 10 years, in order to establish morbidity, mortality and life-quality. 

Methods: Retrospective analysis of 26 children with median age 5,6 years-old, who underwent MVR (17 cases) and AVR (11 cases) between March 1992 and June 2003.

Results: 26 surgeries were performed, implanting 28 prothesis (26 mechanical and 2 biological). 3 patients (12%) died during the first month. The median follow-up period was 6,2 years, with 87% survival. Three patients required new surgery because of non-structural deterioration of the prosthetic valve. All survivors have a normal level of activity according to their age, with restriction only on contact sports. 

Conclusions: Valve replacement in children with severe valvular disease has satisfactory mid-term results.


PDF (Español (España))
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2005 Revista Chilena de Pediatría